Obesity and Diabetes : Scientific Advances and Best Practice /

Now in its second edition, this comprehensive handbook provides a state-of-the-art overview of recent advances in drug and non-drug therapies for obesity and diabetes. It also addresses major comorbidities, covering topics such as, cardiovascular diseases, renal and neuropsychiatric disorders, appet...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Faintuch, Joel (Editor), Faintuch, Salomão (Editor)
Format: eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2020.
Edition:2nd ed. 2020.
Subjects:
Online Access:Connect to the full text of this electronic book
Table of Contents:
  • Introduction to Obesity and Diabetes- The windows of opportunity
  • Nutrition transition and obesity trends in Argentina within the Latin American context
  • Challenges and Economic Burden of Diabetes in Africa
  • Brown adipose tissue in obesity and diabetes
  • White and Brown Adipose Tissue in Obesity and Diabetes
  • microRNAs in obesity and metabolic diseases
  • From Adipogenic Viruses to Anti-Diabetic Drug: A Translational Journey
  • Genetic profiles in the obese population
  • The Upstream Environment for the Obesity Epidemic
  • Inflammation and its role in obesity-related complications
  • Cross talk between adipose tissue, macrophages and other immune cells: Development of obesity and inflammation-induced metabolic diseases
  • Diabetes forecasts and statistics for the coming decades
  • Pancreatic islets of Langerhans: adapting cell and molecular biology to changes of metabolism
  • Targeting advanced glycation end products (esRAGE and sRAGE) for obesity, diabetes and its associated complications
  • Anti-incretin effect: a missing link between obesity, diabetes and metabolic surgery
  • An update on Mendelian forms of obesity and their personalized treatments
  • The Genetic Basis of Diabetic Kidney Disease
  • Epigenetics and chronic inflammation: Role in early detection of type 2 diabetes
  • Salivary and Urinary Metabolome in Pediatric Obesity and Metabolic Syndrome
  • State-of-the-Art Metabolomics Investigations of Type 2 Diabetes
  • The gut microbiome and type 2 diabetes mellitus
  • Immunotherapeutic Approach to the Treatment and Prevention of Obesity
  • Metabolic Syndrome Update
  • Non-alcoholic fatty liver disease: a global public health issue
  • Non-Alcoholic Fatty Pancreatic Disease (NAFPD)
  • Normal weight obesity - A hidden pandemic
  • Obesity in Children/Adolescents and Obesity-Related Comorbidities
  • Obesity and cancer: linked molecular mechanisms
  • Cognitive impairment in obesity and diabetes
  • Metabolic pathways underlying neuropsychiatric disorders and obesity
  • Heart failure and the obesity paradox
  • Inflammatory mechanisms in diabetic kidney disease
  • The epidemiology of the diabetes - depression comorbidity in Brazil -inequality and interaction
  • Contribution of Hyperglycemia and Unhealthy Diet to Cardiovascular Mortality
  • Gestational Diabetes Mellitus
  • Update on Gestational Diabetes
  • Vascular complications in type 2 diabetes
  • What We Know and Don't about High-Intensity Sweeteners
  • Personalised Molecular Feedback for Weight Loss
  • Diabetes and Obesity in the Child and Adolescent: Guidelines and Challenges
  • Type 2 diabetes - an unresolved disease
  • Glucose control in the ICU
  • Continuous glucose monitors as wearable lifestyle behavior change tools in obesity and diabetes
  • Endoscopic techniques for obesity and diabetes
  • Bariatric embolization: a possible non-surgical option for weight reduction
  • Progress in noninvasive beta-cell mass imaging
  • Cancer staging with 18F-FDG PET/CT in hyperglycemic patients
  • Pancreatic Islet Transplantation: A Surgical Approach to Type 1 Diabetes Treatment
  • Pancreatic Transplantation in Diabetes: Indications, Contraindications and Perspectives. -Pharmacotherapy of Type 2 Diabetes
  • GLP1-Receptor Agonists in Diabetes: Drugs, General Effects, and Cardiovascular Impact
  • Diabetes and treatments
  • Treatment of Diabetes and Heart Failure
  • Cardiovascular impact of newer diabetes medications
  • Pathogenesis and Molecular Targets in treatment of Diabetic Wounds
  • Efficiency in public health through the promotion of Diabetes Day Hospitals: a regional proposal
  • Surgical options in obesity and diabetes
  • One anastomosis gastric bypass in the treatment of obesity: effects on body weight and the metabolome
  • Robotic bariatric surgery
  • The Role of Obesity and Bariatric Surgery in the Management of Knee and Hip Osteoarthritis
  • Relapse of diabetes after metabolic/bariatric surgery
  • Malnutrition in Obesity
  • Sugar-Sweetened Beverage Taxes: Origins, Mechanisms, and Current Worldwide Status
  • Mobile Health Interventions for Weight Management in Overweight and Obese Populations
  • Biomarkers and Machine Learning Applications in Obesity
  • Current approaches in diabetes mellitus prediction: applications of machine learning and emerging biomarkers
  • Polycystic ovary syndrome and sarcopenic obesity
  • Drug Pipeline for Obesity Therapy
  • MC4R as a Target for Pharmacotherapeutic Treatment of Obesity and Type-2 diabetes
  • Nanotechnology: Can it be a crusader in diabesity?
  • Old and new anti-obesity devices for medical, surgical, and endoscopical use
  • Electroceutical approaches for gastroparesis
  • Useful Online Resources Hosting Information on Obesity and Diabetes.